Elanco Animal Health (ELAN) Competitors $9.16 -0.56 (-5.71%) Closing price 04/4/2025 03:59 PM EasternExtended Trading$9.16 0.00 (0.00%) As of 04/4/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ELAN vs. TEVA, SMMT, ITCI, GMAB, RDY, MRNA, VTRS, ASND, QGEN, and ROIVShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Viatris (VTRS), Ascendis Pharma A/S (ASND), Qiagen (QGEN), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Moderna Viatris Ascendis Pharma A/S Qiagen Roivant Sciences Teva Pharmaceutical Industries (NYSE:TEVA) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Does the media favor TEVA or ELAN? In the previous week, Teva Pharmaceutical Industries had 22 more articles in the media than Elanco Animal Health. MarketBeat recorded 28 mentions for Teva Pharmaceutical Industries and 6 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.87 beat Teva Pharmaceutical Industries' score of 0.75 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 15 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, TEVA or ELAN? Teva Pharmaceutical Industries has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Do institutionals & insiders hold more shares of TEVA or ELAN? 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are owned by company insiders. Comparatively, 0.6% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer TEVA or ELAN? Teva Pharmaceutical Industries currently has a consensus price target of $23.43, indicating a potential upside of 69.40%. Elanco Animal Health has a consensus price target of $15.17, indicating a potential upside of 65.48%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher possible upside, equities analysts clearly believe Teva Pharmaceutical Industries is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Elanco Animal Health 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Which has higher earnings and valuation, TEVA or ELAN? Elanco Animal Health has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.54B0.95-$1.64B-$1.45-9.54Elanco Animal Health$4.44B1.03-$1.23B$0.6713.68 Is TEVA or ELAN more profitable? Elanco Animal Health has a net margin of 4.60% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Elanco Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-9.91% 42.46% 6.65% Elanco Animal Health 4.60%6.78%3.03% Does the MarketBeat Community believe in TEVA or ELAN? Teva Pharmaceutical Industries received 1193 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.85% of users gave Teva Pharmaceutical Industries an outperform vote while only 54.44% of users gave Elanco Animal Health an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes133467.85% Underperform Votes63232.15% Elanco Animal HealthOutperform Votes14154.44% Underperform Votes11845.56% SummaryTeva Pharmaceutical Industries and Elanco Animal Health tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.55B$6.33B$5.25B$17.77BDividend YieldN/A2.84%4.89%3.78%P/E Ratio22.916.7221.1929.98Price / Sales1.03187.01356.8024.15Price / Cash4.8465.6738.1817.53Price / Book0.735.576.244.13Net Income-$1.23B$141.67M$3.20B$1.02B7 Day Performance-11.83%-11.41%-8.30%-8.66%1 Month Performance-15.41%-16.49%-4.70%-10.76%1 Year Performance-41.06%-18.05%2.67%-5.27% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health3.9066 of 5 stars$9.17-5.7%$15.17+65.5%-40.8%$4.55B$4.44B22.919,800News CoverageGap DownTEVATeva Pharmaceutical Industries2.3655 of 5 stars$15.39+2.0%$23.43+52.3%-0.7%$17.44B$16.54B-10.6136,800Analyst UpgradeShort Interest ↑Analyst RevisionSMMTSummit Therapeutics2.8162 of 5 stars$19.29-5.1%$35.44+83.7%+390.4%$14.23B$700,000.00-68.89110Gap DownITCIIntra-Cellular Therapies3.4582 of 5 stars$131.92+0.1%$106.08-19.6%N/A$14.05B$680.50M-151.63560Analyst ForecastNews CoveragePositive NewsGMABGenmab A/S3.8675 of 5 stars$19.58-1.6%$41.33+111.1%-38.0%$12.96B$21.53B11.251,660Analyst DowngradeGap DownRDYDr. Reddy's Laboratories3.3429 of 5 stars$13.19-0.1%$17.00+28.9%-15.1%$11.01B$311.31B21.0024,800News CoveragePositive NewsGap DownMRNAModerna4.2051 of 5 stars$28.35-8.9%$59.00+108.1%-75.4%$10.96B$3.20B-3.053,900Gap DownVTRSViatris2.5163 of 5 stars$8.71+0.3%$10.50+20.6%-35.2%$10.40B$14.74B-11.7737,000ASNDAscendis Pharma A/S2.9218 of 5 stars$155.86+0.8%$204.64+31.3%-3.4%$9.46B$363.64M-21.951,017News CoveragePositive NewsGap DownQGENQiagen3.9443 of 5 stars$40.17+0.8%$47.71+18.8%-4.3%$8.91B$1.98B111.866,030Analyst DowngradeNews CoverageROIVRoivant Sciences2.25 of 5 stars$10.09-2.8%$17.10+69.5%-17.8%$7.20B$122.59M-67.26860Positive News Remove Ads Related Companies and Tools Related Companies TEVA Competitors SMMT Competitors ITCI Competitors GMAB Competitors RDY Competitors MRNA Competitors VTRS Competitors ASND Competitors QGEN Competitors ROIV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELAN) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELAN Stock Free ELAN Stock Alerts